Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Assess the Impact of Cancer Treatment-Induced Cognitive Impairment on Chronic Pain in Patients With Breast Cancer Over a One-year Period.

NCT07877376 is registered in ClinicalTrials.gov with Nadine ATTAL as lead sponsor.

NCT NCT07877376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07877376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Assess the Impact of Cancer Treatment-Induced Cognitive Impairment on Chronic Pain in Patients With Breast Cancer Over a One-year Period.
Lead sponsor
Nadine ATTAL
Phase
Observational
Overall status
Recruiting
Start date
January 9, 2026
Completion date
March 31, 2028
Enrollment
182 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer